155 related articles for article (PubMed ID: 34315041)
61. Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions.
Maione F; Cantone V; Pace S; Chini MG; Bisio A; Romussi G; Pieretti S; Werz O; Koeberle A; Mascolo N; Bifulco G
Br J Pharmacol; 2017 Jun; 174(11):1497-1508. PubMed ID: 27464306
[TBL] [Abstract][Full Text] [Related]
62. Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.
Rödl CB; Vogt D; Kretschmer SB; Ihlefeld K; Barzen S; Brüggerhoff A; Achenbach J; Proschak E; Steinhilber D; Stark H; Hofmann B
Eur J Med Chem; 2014 Sep; 84():302-11. PubMed ID: 25036790
[TBL] [Abstract][Full Text] [Related]
63. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
64. Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol.
Koeberle A; Northoff H; Werz O
Biochem Pharmacol; 2009 May; 77(9):1513-21. PubMed ID: 19426689
[TBL] [Abstract][Full Text] [Related]
65. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
66. Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.
Koeberle A; Laufer SA; Werz O
J Med Chem; 2016 Jul; 59(13):5970-86. PubMed ID: 26791385
[TBL] [Abstract][Full Text] [Related]
67. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
[TBL] [Abstract][Full Text] [Related]
68. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
69. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
[TBL] [Abstract][Full Text] [Related]
70. Ligand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade.
Saroj Devi N; Shanmugam R; Ghorai J; Ramanan M; Anbarasan P; Doble M
Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991413
[TBL] [Abstract][Full Text] [Related]
71. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA
Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
[TBL] [Abstract][Full Text] [Related]
72. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.
Unangst PC; Shrum GP; Connor DT; Dyer RD; Schrier DJ
J Med Chem; 1992 Oct; 35(20):3691-8. PubMed ID: 1433181
[TBL] [Abstract][Full Text] [Related]
73. Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapy.
Gerstmeier J; Kretzer C; Di Micco S; Miek L; Butschek H; Cantone V; Bilancia R; Rizza R; Troisi F; Cardullo N; Tringali C; Ialenti A; Rossi A; Bifulco G; Werz O; Pace S
Biochem Pharmacol; 2019 Jul; 165():263-274. PubMed ID: 30836057
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
[TBL] [Abstract][Full Text] [Related]
75. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
[TBL] [Abstract][Full Text] [Related]
76. Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915).
Takahashi H; Riether D; Bartolozzi A; Bosanac T; Berger V; Binetti R; Broadwater J; Chen Z; Crux R; De Lombaert S; Dave R; Dines JA; Fadra-Khan T; Flegg A; Garrigou M; Hao MH; Huber J; Hutzler JM; Kerr S; Kotey A; Liu W; Lo HY; Loke PL; Mahaney PE; Morwick TM; Napier S; Olague A; Pack E; Padyana AK; Thomson DS; Tye H; Wu L; Zindell RM; Abeywardane A; Simpson T
J Med Chem; 2015 Feb; 58(4):1669-90. PubMed ID: 25671290
[TBL] [Abstract][Full Text] [Related]
77. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
78. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
[TBL] [Abstract][Full Text] [Related]
79. Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors.
Di Micco S; Terracciano S; Pierri M; Cantone V; Liening S; König S; Garscha U; Hofstetter RK; Koeberle A; Werz O; Bruno I; Bifulco G
ChemMedChem; 2022 Nov; 17(22):e202200327. PubMed ID: 36111583
[TBL] [Abstract][Full Text] [Related]
80. Lipophilic extracts of Leucas zeylanica, a multi-purpose medicinal plant in the tropics, inhibit key enzymes involved in inflammation and gout.
Napagoda M; Gerstmeier J; Butschek H; Lorenz S; Kanatiwela D; Qader M; Nagahawatte A; De Soyza S; Wijayaratne GB; Svatoš A; Jayasinghe L; Koeberle A; Werz O
J Ethnopharmacol; 2018 Oct; 224():474-481. PubMed ID: 29727733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
